GURUFOCUS.COM » STOCK LIST » Technology » Software » Sinopharm Tech Holdings Ltd (HKSE:08156) » Definitions » Cash Flow from Investing

Sinopharm Tech Holdings (HKSE:08156) Cash Flow from Investing : HK$0.00 Mil (TTM As of Dec. 2023)


View and export this data going back to 2002. Start your Free Trial

What is Sinopharm Tech Holdings Cash Flow from Investing?

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

For the three months ended in Dec. 2023, Sinopharm Tech Holdings spent HK$0.00 Mil on purchasing property, plant, equipment. It gained HK$0.00 Mil from selling property, plant, and equipment. It spent HK$0.00 Mil on purchasing business. It gained HK$0.00 Mil from selling business. It spent HK$0.00 Mil on purchasing investments. It gained HK$0.00 Mil from selling investments. It paid HK$0.00Mil for net Intangibles purchase and sale. And it paid HK$0.00 Mil for other investing activities. In all, Sinopharm Tech Holdings gained HK$0.00 Mil on investment activities in financial market and operating subsidiaries for the three months ended in Dec. 2023.


Sinopharm Tech Holdings Cash Flow from Investing Historical Data

The historical data trend for Sinopharm Tech Holdings's Cash Flow from Investing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinopharm Tech Holdings Cash Flow from Investing Chart

Sinopharm Tech Holdings Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Cash Flow from Investing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -23.39 -5.05 -0.09 - -4.86

Sinopharm Tech Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24
Cash Flow from Investing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Sinopharm Tech Holdings Cash Flow from Investing Calculation

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

If a company spends cash on property, plant and equipment (PPE), this will reduce their cash position. This is called Capital Expenditures (CPEX).

Likewise, if a company buys another company for cash, this will reduce their cash position.

Sinopharm Tech Holdings's Cash Flow from Investing for the fiscal year that ended in Jun. 2024 is calculated as:

Sinopharm Tech Holdings's Cash Flow from Investing for the quarter that ended in Dec. 2023 is calculated as:


Cash Flow from Investing for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sinopharm Tech Holdings  (HKSE:08156) Cash Flow from Investing Explanation

Cash flow from investing contains nine items:

1. Purchase Of Property, Plant, Equipment:
Purchase of PPE indicates the amount used to purchase property, plant, and equipment.

Sinopharm Tech Holdings's purchase of property, plant, equipment for the three months ended in Dec. 2023 was HK$0.00 Mil. It means Sinopharm Tech Holdings spent HK$0.00 Mil on purchasing property, plant, equipment.

In the capital spending for property, plant and equipment (PPE), some part of spending may be from the expansion of business. The business needs more property, plant and equipment (PPE) as it grows. Another part may be from replacement of the property, plant and equipment (PPE) of existing business. For some companies, the cash spent on replacing of the property, plant and equipment (PPE) of the existing business will be close to the depreciation of property, plant and equipment (PPE) reported in the income statement.

In Warren Buffett's definition of Owner's Earnings, he deducts the estimate of the cost of replacing the property, plant and equipment (PPE) of the existing business from cash flow from operations. The cash spent on the new property, plant, and equipment is not deducted. The reason is because these are not costs of the existing business. In his 1986 letter to shareholders, Warren Buffett wrote this about owner earnings:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume....Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

2. Sale Of Property, Plant, Equipment:
Sale of PPE indicates the amount gained from selling property, plant, and equipment.

Sinopharm Tech Holdings's sale of property, plant, equipment for the three months ended in Dec. 2023 was HK$0.00 Mil. It means Sinopharm Tech Holdings gained HK$0.00 Mil from selling property, plant, and equipment.

3.Purchase Of Business:
Purchase of business indicates the amount used to purchase business.

Sinopharm Tech Holdings's purchase of business for the three months ended in Dec. 2023 was HK$0.00 Mil. It means Sinopharm Tech Holdings spent HK$0.00 Mil on purchasing business.

4. Sale Of Business:
Sale of business indicates the amount gained from selling business.

Sinopharm Tech Holdings's sale of business for the three months ended in Dec. 2023 was HK$0.00 Mil. It means Sinopharm Tech Holdings gained HK$0.00 Mil from selling business.

5. Purchase Of Investment:
Purchase of Investments represents cash outflow on the purchase of investments in securities.

Sinopharm Tech Holdings's purchase of investment for the three months ended in Dec. 2023 was HK$0.00 Mil. It means Sinopharm Tech Holdings spent {stock_data.stock.currency_symbol}}0.00 Mil on purchasing investments.

6. Sale Of Investment:
Sale of Investments represents cash inflow on the sale of investments in securities.

Sinopharm Tech Holdings's sale of investment for the three months ended in Dec. 2023 was HK$0.00 Mil. It means Sinopharm Tech Holdings gained HK$0.00 Mil from selling investments.

7. Net Intangibles Purchase And Sale:
Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

Sinopharm Tech Holdings's net Intangibles purchase and sale for the three months ended in Dec. 2023 was HK$0.00 Mil. It means Sinopharm Tech Holdings paid HK$0.00 Mil for net Intangibles purchase and sale.

8. Cash From Discontinued Investing Activities:
Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

Sinopharm Tech Holdings's cash from discontinued investing activities for the three months ended in Dec. 2023 was 0.00 Mil. It means Sinopharm Tech Holdings paid HK$0.00 Mil for discontinued investing activities.

9. Cash From Other Investing Activities:
Cash from other investing activities means the cash received by a company that comes from other investing activities.

Sinopharm Tech Holdings's cash from other investing activities for the three months ended in Dec. 2023 was HK$0.00 Mil. It means Sinopharm Tech Holdings paid HK$0.00 Mil for other investing activities.


Sinopharm Tech Holdings Cash Flow from Investing Related Terms

Thank you for viewing the detailed overview of Sinopharm Tech Holdings's Cash Flow from Investing provided by GuruFocus.com. Please click on the following links to see related term pages.


Sinopharm Tech Holdings Business Description

Traded in Other Exchanges
N/A
Address
Ruttonjee Centre, 11 Duddell Street, Unit 1802, 18/F, Ruttonjee House, Hong Kong Central, Hong Kong, HKG
Sinopharm Tech Holdings Ltd is an investment holding company. The company's operating segment includes Lottery-related services; Provision of Internet Plus services (solution and supply chain), Manufacturing and distribution of personal protective equipment, and Others services. It generates maximum revenue from the internet plus services (solution and supply chain) segment. The Internet plus Supply chain services segment includes the provision of supply chain management, data analysis and related services, and trading of goods through the internet platform. Geographically, it derives a majority of revenue from Hong Kong.
Executives
Best Frontier Investments Limited
Chan Kin Ho Philip 2201 Interest of corporation controlled by you
Lam Yui Keung 2201 Interest of corporation controlled by you
Sinopharm Traditional Chinese Medicine Overseas Holdings Limited 2101 Beneficial owner
Main Key Investments Limited 2201 Interest of corporation controlled by you
Guo Lei 2201 Interest of corporation controlled by you
Integrated Asset Management (asia) Limited 2101 Beneficial owner
Yam Tak Cheung 2201 Interest of corporation controlled by you
Chan Tung Mei 2202 Interest of your spouse
Cheung Kwai Lan 2201 Interest of corporation controlled by you
Tse Siu Hoi 2101 Beneficial owner
Gam Star China Equity (a Sub-fund Of Gam Star Fund P.l.c.) 2102 Investment manager

Sinopharm Tech Holdings Headlines

No Headlines